Skip to main content

Advertisement

Log in

Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment

  • Pelvis
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To develop and test radiomics models based on manually corrected or automatically gained masks on ADC maps for pelvic lymph node metastasis (PLNM) prediction in patients with prostate cancer (PCa).

Methods

A primary cohort of 474 patients with PCa who underwent prostate mpMRI were retrospectively enrolled for PLNM prediction between January 2017 and January 2020. They were then randomly split into training/validation (n = 332) and test (n = 142) groups for model development and internal testing. Four radiomics models were developed using four masks (manually corrected/automatic prostate gland and PCa lesion segmentation) based on the ADC maps using the primary cohort. Another cohort of 128 patients who underwent radical prostatectomy (RP) with extended pelvic lymph node dissection (ePLND) for PCa was used as the testing cohort between February 2020 and October 2021. The performance of the models was evaluated in terms of discrimination and clinical usefulness using the area under the curve (AUC) and decision curve analysis (DCA). The optimal radiomics model was further compared with Memorial Sloan Kettering Cancer Center (MSKCC) and Briganti 2017 nomograms, and PI-RADS assessment.

Results

17 (13.28%) Patients with PLNM were included in the testing cohort. The radiomics model based on the mask of automatically segmented prostate obtained the highest AUC among the four radiomics models (0.73 vs. 0.63 vs. 0.70 vs. 0.56). Briganti 2017, MSKCC nomograms, and PI-RADS assessment-yielded AUCs of 0.69, 0.71, and 0.70, respectively, and no significant differences were found compared with the optimal radiomics model (P = 0.605–0.955).

Conclusion

The radiomics model based on the mask of automatically segmented prostate offers a non-invasive method to predict PLNM for patients with PCa. It shows comparable accuracy to the current MKSCC and Briganti nomograms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Code availability

The codes used for the model development are available from the corresponding author on reasonable request.

References

  1. Preisser F, van den Bergh RCN, Gandaglia G, et al. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-institutional Study. J Urol. 2020, 203(2):338–43. doi: https://doi.org/10.1097/ju.0000000000000504

    Article  PubMed  Google Scholar 

  2. Bianchi L, Gandaglia G, Fossati N, et al. Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches. Urologia. 2017,84(1):9–19. doi: https://doi.org/10.5301/uro.5000139

    Article  PubMed  Google Scholar 

  3. Van Huele A, Poelaert F, Fonteyne V, et al. Pelvic lymph node dissection in prostate cancer staging: evaluation of morbidity and oncological outcomes. Acta Chir Belg. 2019, 119(2):103–9. doi: https://doi.org/10.1080/00015458.2018.1470294

    Article  PubMed  Google Scholar 

  4. Briganti A, Blute ML, Eastham JH, et al. Pelvic lymph node dissection in prostate cancer. Eur Urol. 2009, 55(6):1251–65. doi: https://doi.org/10.1016/j.eururo.2009.03.012

    Article  PubMed  Google Scholar 

  5. Briganti A, Larcher A, Abdollah F, et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol. 2012, 61(3):480–7. doi: https://doi.org/10.1016/j.eururo.2011.10.044

    Article  PubMed  Google Scholar 

  6. Gandaglia G, Fossati N, Zaffuto E, et al. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer. Eur Urol. 2017, 72(4):632–40. doi: https://doi.org/10.1016/j.eururo.2017.03.049

    Article  PubMed  Google Scholar 

  7. Gandaglia G, Ploussard G, Valerio M, et al. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies. Eur Urol. 2019, 75(3):506–14. doi: https://doi.org/10.1016/j.eururo.2018.10.012

    Article  PubMed  Google Scholar 

  8. Kim D, Hanna MG, Vanderbilt C, et al. Pathology Informatics Education during the COVID-19 Pandemic at Memorial Sloan Kettering Cancer Center (MSKCC). Acta Med Acad. 2021, 50(1):136–42. doi: https://doi.org/10.5644/ama2006-124.331

    Article  CAS  PubMed  Google Scholar 

  9. Stabile A, Dell'Oglio P, Gandaglia G, et al. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. Eur Urol Oncol. 2018, 1(2):120–8. doi: https://doi.org/10.1016/j.euo.2018.02.002

    Article  PubMed  Google Scholar 

  10. Kasabwala K, Patel N, Cricco-Lizza E, et al. The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-Guided Prostate Biopsy. Eur Urol Oncol. 2019, 2(2):135–40. doi: https://doi.org/10.1016/j.euo.2018.07.005

    Article  PubMed  Google Scholar 

  11. Sun Y, Reynolds HM, Parameswaran B, et al. Multiparametric MRI and radiomics in prostate cancer: a review. Australas Phys Eng Sci Med. 2019, 42(1):3–25. doi: https://doi.org/10.1007/s13246-019-00730-z

    Article  PubMed  Google Scholar 

  12. Rogers W, Thulasi Seetha S, Refaee TAG, et al. Radiomics: from qualitative to quantitative imaging. Br J Radiol. 2020, 93(1108):20190948. doi: https://doi.org/10.1259/bjr.20190948

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hou Y, Bao J, Song Y, et al. Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer. EBioMedicine. 2021, 68:103395. doi: https://doi.org/10.1016/j.ebiom.2021.103395

    Article  PubMed  PubMed Central  Google Scholar 

  14. Schelb P, Kohl S, Radtke JP, et al. Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment. Radiology. 2019, 293(3):607–17. doi: https://doi.org/10.1148/radiol.2019190938

    Article  PubMed  Google Scholar 

  15. Laukamp KR, Thiele F, Shakirin G, et al. Fully automated detection and segmentation of meningiomas using deep learning on routine multiparametric MRI. Eur Radiol. 2019, 29(1):124–32. doi: https://doi.org/10.1007/s00330-018-5595-8

    Article  PubMed  Google Scholar 

  16. Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012,22(4):746–57. doi: https://doi.org/10.1007/s00330-011-2377-y

    Article  PubMed  PubMed Central  Google Scholar 

  17. Anttinen M, Ettala O, Malaspina S, et al. A Prospective Comparison of (18)F-Prostate-Specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-Weighted Imaging, and Single-Photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE). Eur Urol Oncol. 2021, 4(4):635–44. doi: https://doi.org/10.1016/j.euo.2020.06.012

    Article  PubMed  Google Scholar 

  18. Van Damme J, Tombal B, Collette L, et al. Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer. Cancers (Basel). 2021, 13(21). doi: https://doi.org/10.3390/cancers13215286

  19. Zhu Y, Wei R, Gao G, et al. Fully automatic segmentation on prostate MR images based on cascaded fully convolution network. J Magn Reson Imaging. 2019, 49(4):1149–56. doi: https://doi.org/10.1002/jmri.26337

    Article  PubMed  Google Scholar 

  20. Zhu L, Gao G, Liu Y, et al. Feasibility of integrating computer-aided diagnosis with structured reports of prostate multiparametric MRI. Clin Imaging. 2020, 60(1):123–30. doi: https://doi.org/10.1016/j.clinimag.2019.12.010

    Article  PubMed  Google Scholar 

  21. Song Y, Zhang J, Zhang YD, et al. FeAture Explorer (FAE): A tool for developing and comparing radiomics models. PLoS ONE. 2020, 15(8):e0237587. doi: https://doi.org/10.1371/journal.pone.0237587

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. https://github.com/salan668/FAE.

  23. Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019, 76(3):340–51. doi: https://doi.org/10.1016/j.eururo.2019.02.033

    Article  PubMed  Google Scholar 

  24. Mohler JL, Antonarakis ES, Armstrong AJ, et al. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2019, 17(5):479–505. doi: https://doi.org/10.6004/jnccn.2019.0023

    Article  CAS  Google Scholar 

  25. Draulans C, Everaerts W, Isebaert S, et al. Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection. J Urol. 2020, 203(4):713–8. doi: https://doi.org/10.1097/ju.0000000000000652

    Article  PubMed  Google Scholar 

  26. Brembilla G, Dell'Oglio P, Stabile A, et al. Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection. Eur Radiol. 2018, 28(5):1969–76. doi: https://doi.org/10.1007/s00330-017-5229-6

    Article  PubMed  Google Scholar 

  27. Park SY, Shin SJ, Jung DC, et al. PI-RADS version 2: Preoperative role in the detection of normal-sized pelvic lymph node metastasis in prostate cancer. Eur J Radiol. 2017, 91:22–8. doi: https://doi.org/10.1016/j.ejrad.2017.03.009

    Article  PubMed  Google Scholar 

  28. Bourbonne V, Vallières M, Lucia F, et al. MRI-Derived Radiomics to Guide Post-Operative Management for High-Risk Prostate Cancer. Front Oncol. 2019, 9:807. doi: https://doi.org/10.3389/fonc.2019.00807

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wibmer A, Hricak H, Gondo T, et al. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol. 2015, 25(10):2840–50. doi: https://doi.org/10.1007/s00330-015-3701-8

    Article  PubMed  PubMed Central  Google Scholar 

  30. Bourbonne V, Jaouen V, Nguyen TA, et al. Development of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer Patients. Cancers (Basel). 2021, 13(22). doi: https://doi.org/10.3390/cancers13225672

  31. Lohmann P, Bousabarah K, Hoevels M, et al. Radiomics in radiation oncology—basics, methods, and limitations. Strahlenther Onkol. 2020, 196(10):848–55. doi: https://doi.org/10.1007/s00066-020-01663-3

    Article  PubMed  PubMed Central  Google Scholar 

  32. Van Poppel H, Roobol MJ, Chapple CR, et al. Prostate-Specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol. 2021, 80(6):703–11. doi: https://doi.org/10.1016/j.eururo.2021.07.024

    Article  PubMed  Google Scholar 

  33. Hou Y, Bao ML, Wu CJ, et al. A machine learning-assisted decision-support model to better identify patients with prostate cancer requiring an extended pelvic lymph node dissection. BJU Int. 2019, 124(6):972–83. doi: https://doi.org/10.1111/bju.14892

    Article  PubMed  Google Scholar 

  34. Fehr D, Veeraraghavan H, Wibmer A, et al. Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images. Proc Natl Acad Sci U S A. 2015, 112(46):E6265–73. doi: https://doi.org/10.1073/pnas.1505935112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Gandaglia G, Martini A, Ploussard G, et al. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection. Eur Urol. 2020, 78(2):138–42. doi: https://doi.org/10.1016/j.eururo.2020.03.023

    Article  PubMed  Google Scholar 

  36. Shaish H, Kang SK, Rosenkrantz AB. The utility of quantitative ADC values for differentiating high-risk from low-risk prostate cancer: a systematic review and meta-analysis. Abdom Radiol (NY). 2017, 42(1):260–70. doi: https://doi.org/10.1007/s00261-016-0848-y

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by Capital’s Funds for Health Improvement and Research (2020-2-40710).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by XL and ZS. XL performed manual annotation under the supervision of XW. XW, YZ, and XZ performed data interpretation and statistical analysis. The first draft of the manuscript was written by XL and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xiaoying Wang.

Ethics declarations

Conflict of interest

Xiangpeng Wang and Yaofeng Zhang are from a medical technical corporation provided technical support for model development. The authors declare that they have no competing interests.

Ethical approval

This study was approved by the Local Institutional Ethical Committee.

Informed consent

The need for written informed consent was waived.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 24 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, X., Wang, X., Zhang, Y. et al. Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment. Abdom Radiol 47, 3327–3337 (2022). https://doi.org/10.1007/s00261-022-03583-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-022-03583-5

Keywords

Navigation